A normal healthy liver.
Fatty liver disease is one of the most common conditions doctors in India see — and one of the most underappreciated by patients. Most people learn about it incidentally, when an abdominal ultrasound done for some other reason reports "grade 1 fatty liver" or "mild hepatomegaly with fatty changes." The report goes into a folder, the person assumes it's minor, and nothing changes.
That's a mistake. Fatty liver disease affects an estimated 25–30% of Indians, arguably higher in urban populations, and it progresses in a significant minority of untreated cases — from fat accumulation to inflammation, to scarring (fibrosis), to cirrhosis, and occasionally to liver failure or liver cancer. The good news is that in its early stages, it's fully reversible.
The liver stores small amounts of fat normally. When fat constitutes more than 5–10% of the liver's weight, it's diagnosed as fatty liver disease (steatosis).
There are two main types:
Alcoholic fatty liver disease (AFLD): caused by heavy alcohol use. The liver metabolises alcohol, and the process produces fat accumulation alongside toxic byproducts.
Non-alcoholic fatty liver disease (NAFLD): occurs in people who drink little or no alcohol. This is now the most common form worldwide and in India. Related to metabolic factors — obesity, insulin resistance, type 2 diabetes, high triglycerides.
A subset of NAFLD progresses to Non-Alcoholic Steatohepatitis (NASH) — where the fat accumulation is accompanied by inflammation and cell damage. NASH carries significantly higher risk of progression to cirrhosis.
India has one of the highest rates of NAFLD globally, partly due to genetic predisposition to insulin resistance, partly due to high refined carbohydrate diets, and partly because visceral fat accumulation in Indian populations occurs at lower BMI thresholds than in Western populations.
Indians develop metabolic complications at lower body weights than Western populations. A person who appears normal weight or only mildly overweight by BMI can have significant visceral fat and insulin resistance. The liver is extremely sensitive to insulin resistance — and when cells throughout the body resist insulin's signal, the liver is directed to produce and store more fat.
Dietary factors are significant: very high refined carbohydrate intake (large portions of white rice, maida-based foods), high sugar intake from sweets and sweetened drinks, large portions at meals. All of these raise glucose and insulin, driving hepatic fat storage.
Simple steatosis (fatty liver): fat accumulation without significant inflammation. This stage is fully reversible with lifestyle change and carries relatively low risk of progression if addressed.
NASH: fat plus inflammation and cell damage. Higher risk of fibrosis development. Still reversible in early stages but requires more sustained effort. Progression is faster.
Fibrosis: scarring of liver tissue. Earlier fibrosis (F0–F2) can still improve. Significant fibrosis (F3–F4) is harder to reverse.
Cirrhosis: extensive scarring, significant loss of normal liver function. At this stage, the damage to architecture cannot be fully reversed, though slowing further progression is still possible. Decompensated cirrhosis (where the liver can no longer maintain its functions) is a medical emergency.
Hepatocellular carcinoma: liver cancer, which can develop on a background of cirrhosis.
This progression is not inevitable. Most people with simple steatosis don't progress to cirrhosis. But those who don't address it, who have additional risk factors (diabetes, obesity, high alcohol use), or who have NASH rather than simple steatosis are at higher risk.
Most people with fatty liver have no symptoms. This is why it's usually found incidentally.
When symptoms are present:
More advanced disease (fibrosis or cirrhosis) may produce:
Ultrasound of the abdomen is the standard first investigation. It shows echogenic (bright) liver tissue indicating fat accumulation. However, ultrasound doesn't assess the severity of inflammation or fibrosis.
Liver function tests (LFTs): enzymes ALT and AST may be elevated in NASH but can be normal in simple steatosis. Normal LFTs don't rule out fatty liver.
Fibroscan (transient elastography): a non-invasive test that measures liver stiffness, correlating with fibrosis stage. Increasingly available in India and considerably less invasive than biopsy for fibrosis staging.
Blood tests: complete blood count, lipid profile, fasting glucose, HbA1c, insulin level, thyroid function. These establish the metabolic context and associated risk factors.
Blood test being performed.
Liver biopsy: the definitive test for distinguishing simple steatosis from NASH and staging fibrosis. Invasive; reserved for when non-invasive assessment is unclear.
The most important fact: lifestyle changes are the primary treatment for NAFLD, and they work. There is no approved medication specifically for NAFLD at this time (several are in trials). The treatment is diet, exercise, and metabolic risk factor management.
This is the most powerful intervention. Weight loss of 5–10% of body weight produces measurable reduction in liver fat. Weight loss of 7–10% improves NASH inflammation. Weight loss of 10% or more can improve fibrosis.
The rate matters: crash diets and very-low-calorie approaches can temporarily worsen liver inflammation. A modest caloric deficit (300–500 calories below maintenance) producing 0.5–1 kg/week is the evidence-based approach.
Reduce refined carbohydrates and sugar
These are the dominant dietary cause of hepatic fat accumulation in India. Fructose in particular (from sugary drinks, packaged juice, mithai) is directly converted to fat in the liver. Cut sugary drinks completely. Reduce white rice portions, maida-based items, and sweet snacks.
Increase fibre
Soluble fibre from oats, dals, vegetables, and fruits reduces fat absorption and improves the gut microbiome, which interacts with liver metabolism.
Adequate protein
Protein at every meal — dal, eggs, paneer, curd, fish — supports liver repair, prevents muscle loss during weight loss, and improves satiety.
Healthy fats in moderation
Omega-3 fatty acids (fatty fish, walnuts, flaxseeds) reduce liver inflammation. Replace vanaspati and excessive refined oil with small amounts of mustard oil, olive oil, or ghee.
Coffee
Regular coffee consumption is associated with reduced liver fat, reduced inflammation, and lower fibrosis risk. Several cups daily of plain coffee (without excessive sugar) is beneficial for liver health specifically — this is one of the more robust nutritional findings in hepatology.
Avoid alcohol
Even people with NAFLD (non-alcoholic) should minimise alcohol. The liver processing alcohol while already under metabolic stress worsens damage significantly.
Reduce ultra-processed foods and trans fats
Vanaspati, most commercial biscuits and snacks, packaged foods with hydrogenated fats. These promote inflammation directly.
Both aerobic exercise and resistance training independently reduce liver fat, even without significant weight loss.
30 minutes of moderate aerobic exercise (brisk walking, cycling, swimming) five days a week reduces liver fat measurably within weeks.
Resistance training (squats, lunges, push-ups, weights) adds independent metabolic benefits by building muscle and improving insulin sensitivity.
Even reducing prolonged sitting — getting up and walking every hour during desk work — has documented liver health effects.
Insulin resistance is the core metabolic driver of NAFLD. Managing it through diet, exercise, and weight loss improves liver fat simultaneously.
For those with prediabetes or type 2 diabetes, medical management of blood sugar (dietary change, metformin, or other medications as prescribed) is central to fatty liver treatment.
High triglycerides often accompany NAFLD and worsen prognosis. The dietary changes that reduce liver fat (less sugar, less refined carbohydrate, more fibre, omega-3s) also lower triglycerides.
Hypothyroidism promotes both weight gain and hepatic fat accumulation. Treating it doesn't fix fatty liver, but removing this contributing factor matters.
Several medications can cause drug-induced fatty liver: corticosteroids, tamoxifen, amiodarone, some antiretrovirals. Discuss any concerns with your doctor.
Some herbal supplements can cause liver injury — including some marketed as "liver protective." Discuss any supplements with your doctor.
Alcohol: even moderate drinking worsens NAFLD. If you have fatty liver, the safest approach is complete abstinence for the duration of reversal (at minimum).
Very rapid weight loss: starvation or very low-calorie diets can worsen liver inflammation.
Fructose in all forms: sugary drinks, packaged juice, large amounts of fruit juice, mithai with glucose-fructose syrup. The liver processes fructose directly into fat.
Unnecessary supplements: herbal "liver tonics" and detox products have no proven benefit and some have demonstrated hepatotoxicity.
Sedentary living: the liver responds most to moving regularly.
With consistent lifestyle changes:
Fibrosis (scarring) improves more slowly and requires more sustained effort — years, not months.
People with NAFLD should have:
At Prakash Hospital Noida, our gastroenterologists and hepatologists evaluate and manage fatty liver disease — from initial diagnosis through lifestyle counselling, metabolic risk factor management, monitoring, and specialist care for advanced fibrosis. Ultrasound, liver function tests, fibroscan referral, and diabetes and lipid management are all available.
Whether you're in Sector 18, Sector 62, Greater Noida West, or anywhere nearby, Prakash Hospital Noida is a trusted name for gastroenterology, liver health, and metabolic disease management in Noida.
CopyWe offer expert care across key specialties, including Medicine, Cardiology, Orthopaedics, ENT, Gynaecology, and more—delivering trusted treatment under one roof.
Dr. Divyajyoti Sharma
Prakash Hospital Pvt. Ltd. is a 100 bedded NABH NABL accredited multispecialty hospital along with a center of trauma and orthopedics. We are in the service of society since 2001.
OUR SPECIALITIES
Patient Services
PROCEDURES
Contact Us
D – 12A, 12B, Sector-33, G. B. Nagar, Noida, Uttar Pradesh 201301
+91-8826000033
© 2026 All rights reserved.
Designed and Developed by Zarle Infotech
